3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
69
Glioma
26
Brain Neoplasms
26
Gliosarcoma
23
Melanoma
17
Central Nervous System Neoplasms
14
Astrocytoma
12
Neuroblastoma
10
Rhabdomyosarcoma
8
Small Cell Lung Carcinoma
6
Sarcoma, Ewing
6
Neoplasms
6
Neoplasm Metastasis
6
Medulloblastoma
6
Recurrence
5
Sarcoma
4
Ovarian Neoplasms
4
Osteosarcoma
4
Oligodendroglioma
4
Wilms Tumor
3
Prostatic Neoplasms
3
Neuroectodermal Tumors, Primitive, Peripheral
3
Ependymoma
3
Diffuse Intrinsic Pontine Glioma
3
Breast Neoplasms
3
Rhabdoid Tumor
2
Pancreatic Neoplasms
2
Optic Nerve Glioma
2
Lymphoma, Follicular
2
Lymphoma
2
Interventions
Radiosurgery
2
ibrutinib
1
Temozolomide
1
Lenalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Neurologic Manifestations
×
Temozolomide
×
Clear all
NCT01120639
2021-08-06
Tx-Treatment
Stanford University
Phase 1/2
Completed
30 enrolled
19 charts